Also trades as: INDV.L (LSE) · $vol 5M
INDV NASDAQ
Indivior Pharmaceuticals Inc
1W: -1.0%
1M: +12.2%
3M: +10.5%
YTD: +4.8%
1Y: +227.4%
3Y: +98.0%
5Y: +263.7%
$37.53
+0.07 (+0.19%)
Weekly Expected Move ±5.8%
$33
$35
$37
$39
$41
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1B
Revenue
+10.2% YoY
$251M
Net Income
+1830.8% YoY
$-185M
Free Cash Flow
-240.6% YoY
87.4%
Gross Margin
43.2%
Op. Margin
28.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-112.6%
ROA19.9%
ROIC548.6%
Valuation
P/E18.7
P/B-32.7
EV/EBITDA10.2
Leverage
Debt/Equity-3.58
Current Ratio0.71
Interest Cov.9.6x
Quality Scores
Piotroski F4/9
Altman Z3.40
Beneish M-1.01